These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12678056)

  • 21. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
    Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
    Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of H63D, S65C, and C282Y hereditary hemochromatosis gene variants in Madeira Island (Portugal).
    Spínola C; Brehm A; Spínola H
    Ann Hematol; 2011 Jan; 90(1):29-32. PubMed ID: 20714725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound heterozygote (C282Y/H63D) of hereditary hemochromatosis in a 16-year-old girl with hypoplastic kidney.
    Kaczorowska-Hac B; Sikorska K; Bielawski KP; Schramm K; Balcerska A
    Int J Hematol; 2007 May; 85(4):300-3. PubMed ID: 17483072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis.
    Bittencourt PL; Palácios SA; Couto CA; Cançado EL; Carrilho FJ; Laudanna AA; Kalil J; Gayotto LC; Goldberg AC
    Braz J Med Biol Res; 2002 Mar; 35(3):329-35. PubMed ID: 11887210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.
    Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M
    Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of three hereditary hemochromatosis mutant alleles in the Michigan Caucasian population.
    Barry E; Derhammer T; Elsea SH
    Community Genet; 2005; 8(3):173-9. PubMed ID: 16113534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic hemochromatosis update.
    Brissot P; Le Lan C; Lorho R; Gaboriau F; Lescoat G; Loréal O
    Acta Gastroenterol Belg; 2005; 68(1):33-7. PubMed ID: 15832585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical penetrance of C282Y homozygous HFE hemochromatosis in a western Romanian population.
    Neghina AM; Anghel A; Sporea I; Popescu A
    J Gastrointestin Liver Dis; 2011 Mar; 20(1):100-1. PubMed ID: 21451811
    [No Abstract]   [Full Text] [Related]  

  • 29. Validation of an unlabeled probe melting analysis assay combined with high-throughput extractions for genotyping of the most common variants in HFE-associated hereditary hemochromatosis, C282Y, H63D, and S65C.
    Sumner K; Hubley L; Pont-Kingdon G; Mitchell S; Wayman T; Wilson A; Meadows C; Elenitoba-Johnson K; Pattison D; Dobrowolski S; Best H; Lyon E
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):656-60. PubMed ID: 22364140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of HFE gene mutations (C282Y, H63D, and S65C) in the Ecuadorian population.
    Leone PE; Giménez P; Collantes JC; Paz-y-Miño C
    Ann Hematol; 2005 Feb; 84(2):103-5. PubMed ID: 15517265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A primer for predicting risk of disease in HFE-linked hemochromatosis.
    Adams PC; Walker AP; Acton RT
    Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HFE based re-evaluation of heterozygous hemochromatosis.
    Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
    Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetrance of the C28Y/C282Y genotype of the HFE gene.
    Asberg A; Hveem K; Kannelønning K; Irgens WØ
    Scand J Gastroenterol; 2007 Sep; 42(9):1073-7. PubMed ID: 17710673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary hemochromatosis.
    Fix OK; Kowdley KV
    Minerva Med; 2008 Dec; 99(6):605-17. PubMed ID: 19034258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
    Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and spectrum of hemochromatosis mutations in Tunisia.
    Zorai A; Harteveld CL; Rachdi R; Dellagi K; Abbes S; Delbini P; Giordano PC
    Hematol J; 2003; 4(6):433-5. PubMed ID: 14671616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HFE mutation H63D predicts risk of iron over load in thalassemia intermedia irrespective of blood transfusions.
    Sharma V; Panigrahi I; Dutta P; Tyagi S; Choudhry VP; Saxena R
    Indian J Pathol Microbiol; 2007 Jan; 50(1):82-5. PubMed ID: 17474269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of the HFE gene mutations in five Italian populations.
    Candore G; Mantovani V; Balistreri CR; Lio D; Colonna-Romano G; Cerreta V; Carru C; Deiana L; Pes G; Menardi G; Perotti L; Miotti V; Bevilacqua E; Amoroso A; Caruso C
    Blood Cells Mol Dis; 2002; 29(3):267-73. PubMed ID: 12547216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.